212 related articles for article (PubMed ID: 14616426)
1. The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination scheme.
Ranganathan SS; Houghton JE; Davies DP; Routledge PA
Br J Clin Pharmacol; 2003 Dec; 56(6):658-63. PubMed ID: 14616426
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
3. Reported paediatric adverse drug reactions in the UK 2000-2009.
Hawcutt DB; Mainie P; Riordan A; Smyth RL; Pirmohamed M
Br J Clin Pharmacol; 2012 Mar; 73(3):437-46. PubMed ID: 21988288
[TBL] [Abstract][Full Text] [Related]
4. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.
McLernon DJ; Bond CM; Hannaford PC; Watson MC; Lee AJ; Hazell L; Avery A;
Drug Saf; 2010 Sep; 33(9):775-88. PubMed ID: 20701410
[TBL] [Abstract][Full Text] [Related]
5. Developing an adverse drug reaction reporting system at a teaching hospital.
Baniasadi S; Fahimi F; Shalviri G
Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):408-11. PubMed ID: 18312492
[TBL] [Abstract][Full Text] [Related]
6. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
Ball D; Tisócki T
Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
[TBL] [Abstract][Full Text] [Related]
7. A novel scheme for the reporting of adverse drug reactions.
Clarkson A; Ingleby E; Choonara I; Bryan P; Arlett P
Arch Dis Child; 2001 Apr; 84(4):337-9. PubMed ID: 11259235
[TBL] [Abstract][Full Text] [Related]
8. [Adverse drug reactions following immunization in Germany pursuant to the German Infection Protection Act and the German Medicinal Products Act from January 1, 2004 to December 31, 2005].
Weisser K; Meyer C; Petzold D; Mentzer D; Keller-Stanislawski B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Nov; 50(11):1404-17. PubMed ID: 17999134
[TBL] [Abstract][Full Text] [Related]
9. The spontaneous reporting of adverse drug reactions by nurses.
Hall M; McCormack P; Arthurs N; Feely J
Br J Clin Pharmacol; 1995 Aug; 40(2):173-5. PubMed ID: 8562303
[TBL] [Abstract][Full Text] [Related]
10. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
11. Adverse drug reaction reporting by community pharmacists-The barriers and facilitators.
Hughes ML; Weiss M
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1552-1559. PubMed ID: 31131966
[TBL] [Abstract][Full Text] [Related]
12. Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting Indicator.
Deslandes PN; Bracchi R; Jones K; Haines KE; Carey E; Adams A; Walker J; Thomas A; Routledge PA
Br J Clin Pharmacol; 2022 Aug; 88(8):3829-3836. PubMed ID: 35322450
[TBL] [Abstract][Full Text] [Related]
13. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
Smith CC; Bennett PM; Pearce HM; Harrison PI; Reynolds DJ; Aronson JK; Grahame-Smith DG
Br J Clin Pharmacol; 1996 Oct; 42(4):423-9. PubMed ID: 8904613
[TBL] [Abstract][Full Text] [Related]
14. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.
Sweis D; Wong IC
Drug Saf; 2000 Aug; 23(2):165-72. PubMed ID: 10945377
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
Aagaard L; Weber CB; Hansen EH
Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
[TBL] [Abstract][Full Text] [Related]
16. Reporting of adverse drug reactions by nurses.
Morrison-Griffiths S; Walley TJ; Park BK; Breckenridge AM; Pirmohamed M
Lancet; 2003 Apr; 361(9366):1347-8. PubMed ID: 12711472
[TBL] [Abstract][Full Text] [Related]
17. Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study.
Bryan P; Seabroke S; Wong J; Donegan K; Webb E; Goldsmith C; Vipond C; Feavers I
Lancet Child Adolesc Health; 2018 Jun; 2(6):395-403. PubMed ID: 30169281
[TBL] [Abstract][Full Text] [Related]
18. Reporting of adverse drug reactions by hospital doctors and the response to intervention.
McGettigan P; Golden J; Conroy RM; Arthur N; Feely J
Br J Clin Pharmacol; 1997 Jul; 44(1):98-100. PubMed ID: 9241104
[TBL] [Abstract][Full Text] [Related]
19. A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme.
Bracchi RC; Houghton J; Woods FJ; Thomas S; Smail SA; Routledge PA
Br J Clin Pharmacol; 2005 Aug; 60(2):221-3. PubMed ID: 16042677
[TBL] [Abstract][Full Text] [Related]
20. Review of yellow cards (1986): report to the Committee on the Safety of Medicines.
Bem JL; Breckenridge AM; Mann RD; Rawlins MD
Br J Clin Pharmacol; 1988 Dec; 26(6):679-89. PubMed ID: 3242573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
